CY1105135T1 - Ιξωδοελαστικες οφθαλμικες συνθεσεις οι οποιες πepιλαμβανουν υαλουρονικο οξυ και θειϊκη χονδροϊτινη - Google Patents
Ιξωδοελαστικες οφθαλμικες συνθεσεις οι οποιες πepιλαμβανουν υαλουρονικο οξυ και θειϊκη χονδροϊτινηInfo
- Publication number
- CY1105135T1 CY1105135T1 CY20061100396T CY061100396T CY1105135T1 CY 1105135 T1 CY1105135 T1 CY 1105135T1 CY 20061100396 T CY20061100396 T CY 20061100396T CY 061100396 T CY061100396 T CY 061100396T CY 1105135 T1 CY1105135 T1 CY 1105135T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hyaluronic acid
- ophthalmic compositions
- chondroitin sulphate
- compositions incorporating
- incorporating hyaluronic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 229920001287 Chondroitin sulfate Polymers 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 208000002177 Cataract Diseases 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Μια βελτιωμένη ιξωδοελαστική σύνθεση χρήσιμη στην εκτέλεση οφθαλμικών επεμβάσεων και ιδιαίτερα επεμβάσεων καταρράκτη γνωστοποιείται. Οι συνθέσεις περιλαμβάνουν συνδυασμούς υαλουρονικού οξέος και θειικής χονδροϊτίνης και εμφανίζουν ένα βελτιωμένο ρεολογικό προφίλ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34291801P | 2001-12-21 | 2001-12-21 | |
PCT/US2002/036548 WO2003057187A1 (en) | 2001-12-21 | 2002-11-13 | Combinations of viscoelastics for use during surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105135T1 true CY1105135T1 (el) | 2009-11-04 |
Family
ID=23343846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100396T CY1105135T1 (el) | 2001-12-21 | 2006-03-21 | Ιξωδοελαστικες οφθαλμικες συνθεσεις οι οποιες πepιλαμβανουν υαλουρονικο οξυ και θειϊκη χονδροϊτινη |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1455750B1 (el) |
JP (2) | JP4480131B2 (el) |
KR (1) | KR100648771B1 (el) |
AR (1) | AR037794A1 (el) |
AT (1) | ATE317256T1 (el) |
AU (1) | AU2002350186B2 (el) |
BR (1) | BRPI0215189B8 (el) |
CA (1) | CA2470466C (el) |
CY (1) | CY1105135T1 (el) |
DE (1) | DE60209144T2 (el) |
DK (1) | DK1455750T3 (el) |
ES (1) | ES2253571T3 (el) |
HK (1) | HK1066163A1 (el) |
MX (1) | MXPA04006032A (el) |
NZ (1) | NZ533483A (el) |
TW (1) | TWI256896B (el) |
WO (1) | WO2003057187A1 (el) |
ZA (1) | ZA200404533B (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1455750B1 (en) * | 2001-12-21 | 2006-02-08 | Alcon, Inc. | Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate |
US20060073184A1 (en) * | 2004-09-29 | 2006-04-06 | Bausch & Lomb Inc. | Viscoelastic composition, methods of use and packaging device with anti-oxidant |
AU2005309555A1 (en) * | 2004-11-23 | 2006-06-01 | Alcon, Inc. | Triple natural polymer viscoelastic composition |
WO2007008206A1 (en) * | 2005-07-11 | 2007-01-18 | Alcon, Inc. | Dilution resistant viscoelastic compositions |
AU2006287485B2 (en) * | 2005-09-07 | 2012-07-12 | Amo Regional Holdings | Bi-modal hyaluronate solution |
EP1964924B1 (en) * | 2005-12-15 | 2015-09-30 | Seikagaku Corporation | Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin |
US8398611B2 (en) * | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
AR108280A1 (es) * | 2016-05-05 | 2018-08-08 | Acraf | Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo |
US20210220515A1 (en) * | 2018-05-25 | 2021-07-22 | Eyebright Medical Technology (Beijing) Co., Ltd. | Viscoelastic agent material |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627162A (en) * | 1990-01-11 | 1997-05-06 | Gwon; Arlene E. | Methods and means for control of proliferation of remnant cells following surgery |
US5273056A (en) * | 1992-06-12 | 1993-12-28 | Alcon Laboratories, Inc. | Use of combinations of viscoelastics during surgery |
ES2343402T3 (es) * | 2000-03-14 | 2010-07-30 | Alcon, Inc. | Viscoelasticos para uso en cirugia del oido medio. |
EP1455750B1 (en) * | 2001-12-21 | 2006-02-08 | Alcon, Inc. | Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate |
-
2002
- 2002-11-13 EP EP02786715A patent/EP1455750B1/en not_active Expired - Lifetime
- 2002-11-13 WO PCT/US2002/036548 patent/WO2003057187A1/en active IP Right Grant
- 2002-11-13 DE DE60209144T patent/DE60209144T2/de not_active Expired - Lifetime
- 2002-11-13 JP JP2003557545A patent/JP4480131B2/ja not_active Expired - Lifetime
- 2002-11-13 AT AT02786715T patent/ATE317256T1/de active
- 2002-11-13 DK DK02786715T patent/DK1455750T3/da active
- 2002-11-13 AU AU2002350186A patent/AU2002350186B2/en not_active Expired
- 2002-11-13 ES ES02786715T patent/ES2253571T3/es not_active Expired - Lifetime
- 2002-11-13 KR KR1020047009784A patent/KR100648771B1/ko active IP Right Grant
- 2002-11-13 NZ NZ533483A patent/NZ533483A/xx not_active IP Right Cessation
- 2002-11-13 MX MXPA04006032A patent/MXPA04006032A/es active IP Right Grant
- 2002-11-13 CA CA002470466A patent/CA2470466C/en not_active Expired - Lifetime
- 2002-11-13 BR BRPI0215189A patent/BRPI0215189B8/pt not_active IP Right Cessation
- 2002-12-11 AR ARP020104802A patent/AR037794A1/es unknown
- 2002-12-20 TW TW091136909A patent/TWI256896B/zh not_active IP Right Cessation
-
2004
- 2004-06-08 ZA ZA2004/04533A patent/ZA200404533B/en unknown
- 2004-11-16 HK HK04109043A patent/HK1066163A1/xx not_active IP Right Cessation
-
2006
- 2006-03-21 CY CY20061100396T patent/CY1105135T1/el unknown
-
2009
- 2009-12-14 JP JP2009283469A patent/JP2010070556A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2002350186A1 (en) | 2003-07-24 |
JP2005516027A (ja) | 2005-06-02 |
WO2003057187A1 (en) | 2003-07-17 |
TW200302106A (en) | 2003-08-01 |
JP4480131B2 (ja) | 2010-06-16 |
ES2253571T3 (es) | 2006-06-01 |
NZ533483A (en) | 2006-03-31 |
DK1455750T3 (da) | 2006-04-10 |
JP2010070556A (ja) | 2010-04-02 |
WO2003057187A8 (en) | 2004-07-08 |
BR0215189A (pt) | 2004-11-16 |
BRPI0215189B8 (pt) | 2021-05-25 |
AU2002350186B2 (en) | 2007-07-05 |
BRPI0215189B1 (pt) | 2016-03-08 |
KR20040075898A (ko) | 2004-08-30 |
TWI256896B (en) | 2006-06-21 |
HK1066163A1 (en) | 2005-03-18 |
EP1455750B1 (en) | 2006-02-08 |
KR100648771B1 (ko) | 2006-11-23 |
EP1455750A1 (en) | 2004-09-15 |
ATE317256T1 (de) | 2006-02-15 |
ZA200404533B (en) | 2005-08-31 |
AR037794A1 (es) | 2004-12-01 |
DE60209144T2 (de) | 2006-08-17 |
CA2470466A1 (en) | 2003-07-17 |
DE60209144D1 (de) | 2006-04-20 |
MXPA04006032A (es) | 2005-03-31 |
CA2470466C (en) | 2009-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105135T1 (el) | Ιξωδοελαστικες οφθαλμικες συνθεσεις οι οποιες πepιλαμβανουν υαλουρονικο οξυ και θειϊκη χονδροϊτινη | |
BR0111233A (pt) | Sulfato de bário micronizado | |
AU2003249606A1 (en) | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof | |
BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
BR0204980B1 (pt) | Composições cosméticas que contêm pelo menos um silicone aminado e um agente espessante, uso de uma composição, uso de pelo menos um silicone aminado e processo de tratamento das matérias queratínicas | |
BRPI0518050A (pt) | composição para debridamento a partir da bromelina e métodos para produção da mesma | |
CY1105009T1 (el) | Συνθεση καχαλαλιδης f | |
BRPI0409206B8 (pt) | composições compreendendo cepas de lactobacillus em combinação com tanino e uso das referidas cepas de lactobacillus | |
PL373465A1 (en) | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives | |
ATE466583T1 (de) | Viskoelastische substanzen zur verwendung bei mittelohr operationen | |
BR0313148A (pt) | Formulações de liberação controlada compreendendo lamotrigina | |
AR034343A1 (es) | Combinaciones farmaceuticas | |
BR0315644A (pt) | Piperazinil e diazapanil benzamidas e benzotioamidas | |
AU2003223224A1 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
DE60219438D1 (de) | Dentalmaterial gegen karies | |
ATE365735T1 (de) | Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel | |
GT199900003A (es) | Polisacaridos de sintesis, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
WO2004091436A3 (en) | Methods and compositions for treating ocular disease | |
ITMI20000226A0 (it) | Derivati del benzossazolo loro impiego in composizioni cosmetiche e nella stabilizzazione di polimeri sintetici | |
BRPI0407335A (pt) | Agentes antibacterianos | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
BR0115154A (pt) | material viscoelástico transicional não-aspirante para uso em cirurgia | |
AU2002342498A1 (en) | Organic compounds |